phosphorylethanolamine and sulbactam

phosphorylethanolamine has been researched along with sulbactam in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Doi, Y; Ernst, RK; Hittle, LE; O'Hara, JA; Pasculle, AW; Qureshi, ZA; Rivera, JI; Shields, RK; Syed, A1
Abe, S; Badavath, VN; Chatsuwan, T; Gan, L; Higgins, PG; Hongsing, P; Hurst, C; Kueakulpattana, N; Kupwiwat, R; Leelahavanichkul, A; Liao, T; Luk-In, S; Phattharapornjaroen, P; Saethang, T; Shein, AMS; Srisakul, S; Tanasatitchai, C; Wannigama, DL; Wapeesittipan, P1

Other Studies

2 other study(ies) available for phosphorylethanolamine and sulbactam

ArticleYear
Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, May-01, Volume: 60, Issue:9

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Ampicillin; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Electronic Health Records; Electrophoresis, Gel, Pulsed-Field; Ethanolamines; Female; Humans; Lipid A; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Pneumonia, Ventilator-Associated; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sulbactam

2015
Overcoming addition of phosphoethanolamine to lipid A mediated colistin resistance in Acinetobacter baumannii clinical isolates with colistin-sulbactam combination therapy.
    Scientific reports, 2022, 07-06, Volume: 12, Issue:1

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Colistin; Ethanolamines; Humans; Lipid A; Microbial Sensitivity Tests; Phosphatidylethanolamines; Sulbactam

2022